| Psoriasis |
1 |
1 |
| Biosimilars |
0 |
0.99 |
| Biologic Therapy |
0 |
0.98 |
| France |
0 |
0.25 |
| Healthcare and Medical Technology |
0 |
0.1 |
| Match |
0 |
0.1 |
| Medical Life |
0 |
0.1 |
| NHS |
0 |
0.08 |
| Health Insurance |
0 |
0.07 |
| Revenue and Practice Management |
0 |
0.07 |
| Tumor Necrosis Factor-Alpha |
0 |
0.07 |